Specially, in the setting of advanced cancer, LAG-3 is preferentially expressed on tumor-infiltrating Tregs (149) and these Tregs display a terminal effector phenotype and proliferate less than LAG3− Tregs (150). The gene discussed is LAG3; the disease is neoplasm.